- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT00783185
Dual Diagnosis (Psychosis and Cannabismisuse): Comparison of Specialized Treatment Versus Unspecified Treatment
Dual Diagnosis Psychosis and Substance Abuse: Short- and Middle-term Changes in Symptomatology After Visiting a Group Education Programme to Reduce Consumption of Cannabis
Intention of the study is to examine, if the symptomatology of dual diagnosis patients is less severe after a special indication training for reduction of cannabis consumption in comparison to unspecified trainings.
Point of interest is psychopathology and consumerism.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Dual diagnosis patients (psychosis and cannabis abuse) account for more clinical admissions than single diagnosis patients.
Cannabis misuse is a known risk factor for recurrence of psychosis.
A specified intervention on the basis of a manual for schizophrenic substance abusers is administered to inpatients in a specialized unit for young schizophrenic patients in a psychiatric hospital.
The control group, same indication (psychotic disorder and cannabis misuse) receives social competence training (specified for schizophrenic patients as well).
Admission to groups is randomly.
Undersøgelsestype
Tilmelding (Forventet)
Fase
- Fase 1
Kontakter og lokationer
Studiesteder
-
-
Baden-Württemberg
-
Konstanz, Baden-Württemberg, Tyskland, 78462
- University of Konstanz
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Clinical diagnosis of schizophrenia and disorders with psychotic features
- Misuse of cannabis during 12 months preceding admission to hospital
Exclusion Criteria:
- Not able to attend training twice a week for 45 minutes (concentration, attention, psychotic symptoms, agitation)
- Discharge from hospital before completion of training
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Eksperimentel: ACT
Anti-Cannabis-Consumption-Training
|
8 sessions within 4 weeks (twice a week, 45 minutes each) Cognitive behavioral therapy with focus on cannabis abuse
|
Aktiv komparator: CG
Control group
|
8 sessions within 4 weeks (twice a week, 45 minutes) training to develop and ameliorate social competences
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
---|---|
PANSS Positive and Negative Symptom Scale
Tidsramme: post intervention, six months follow-up
|
post intervention, six months follow-up
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
---|---|
Urinstatus for cannabinoids
Tidsramme: weekly during and post intervention, follow-up
|
weekly during and post intervention, follow-up
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Ledende efterforsker: Hans Watzl, Dr., University of Konstanz
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- CRET
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Cannabis-Consumption-Reduction-Training
-
University of WashingtonNational Institute of Mental Health (NIMH)RekrutteringImplicit biasForenede Stater